Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KL5M
|
|||
| Drug Name |
PMID25656651-Compound-38
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ASTAR BIOTECH LLC HUANG, Haihong YU, Chunrong ZHANG, Dongfeng LI, Peng
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C30H28F2N6O
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(=O)NC2=CC3=C(C=C2)C(CC3(F)F)N4CCN(CC4)C)C#CC5=CN=C6N5N=CC=C6
|
|||
| InChI |
1S/C30H28F2N6O/c1-20-5-6-22(16-21(20)7-9-24-19-33-28-4-3-11-34-38(24)28)29(39)35-23-8-10-25-26(17-23)30(31,32)18-27(25)37-14-12-36(2)13-15-37/h3-6,8,10-11,16-17,19,27H,12-15,18H2,1-2H3,(H,35,39)
|
|||
| InChIKey |
BPLVEFPXYUJTQJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.